On (b)(6) 2024, this peritoneal dialysis (pd) patient on continuous cyclic pd (ccpd) therapy utilizing the liberty select cycler reported to fresenius technical services they needed to discontinue a pd treatment to go to the hospital for a fever.There was no specific allegation this adverse event was related to a deficiency or malfunction of any fresenius product(s) or device(s) in the initial reporting.Upon follow up with the patient¿s pd registered nurse, it was reported this patient was hospitalized on (b)(6) 2024 following fever, abdominal pain and cloudy peritoneal effluent fluid.It was explained laboratory testing was conducted in the hospital but not reported to the outpatient clinic as the patient was still awaiting discharge to home.The patient was diagnosed with peritonitis due to unknown etiology.The patient was prescribed intravenous levofloxacin at 500 mg daily to address this infection while hospitalized.The patient has been able to undergo ccpd therapy on a hospital provided cycler (unknown brand and model) for the duration of the admission.The patient is recovering from this event while awaiting discharge home.It was confirmed, though the exact cause of this infection remains unknown, there was no indication the patient¿s peritonitis, and the associated hospitalization were due to a deficiency or malfunction of any fresenius product(s) or device(s).The patient plans to continue ccpd therapy on the same liberty select cycler at home upon discharge.
|